50 employees
Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.
2023
$36M
from 3 investors over 3 rounds
Larkspur Biosciences raised $36M on May 23, 2023
Investors: 3E Bioventures Capital, Takeda UK Limited and Polaris Partners